CynergisTek’s Resilience Partner Program helps southern medical system amp up cybersecurity defenses.
AUSTIN, TX (January 5, 2021) – CynergisTek (NYSE American: CTEK), leading cybersecurity, privacy, compliance, and IT audit firm helping organizations in highly regulated industries navigate emerging security and privacy issues, recently announced it has signed a 6-figure, multi-year Resilience Partner Program (RPP) agreement to provide annual cybersecurity risk assessments, testing, and advisory services for a leading, nationally recognized, community-owned medical system. This alliance will allow the healthcare system to reduce its risk of a cyber-attack and help them achieve its cybersecurity goals.
“We look forward to serving this client with our Resilience Partner Program and we understand the need to provide healthcare organizations support to not only discover gaps, but to also figure out how to prioritize remediation and stick around for advisory support,” said Mac McMillan, CEO, and President at CynergisTek. “The threat environment has increased through the pandemic, with more cyber-attacks and criminal behavior being directed towards the healthcare industry just as the environment has become more vulnerable. The cost of these cyber events is rising sharply with cyber insurance premiums and compliance requirements increasing. To meet these challenges CynergisTek continues to partner with our clients, roll out services, and evolve our existing services resulting in 2021 being our strongest annual bookings year in the last three.” he says.
CynergisTek’s Resilience Partner Program is designed to support the needs of its healthcare clients to better position them to protect against cyber threats. This program offers annual risk assessments, medical device security, vendor security management, technical testing, control validation, advisory support, and remediation guidance that is aimed to help healthcare organizations prioritize risk, maintain a constant eye on risks associated with the expanding threat landscape, and ensure they have a strong and effective approach to risk that responds every day.
About CynergisTek, Inc.
CynergisTek (www.cynergistek.com), is a top-ranked cybersecurity consulting firm helping organizations in highly regulated industries, including those in healthcare, government, and finance navigate emerging security and privacy issues. CynergisTek combines intelligence, expertise, and a distinct methodology to validate a company's security posture and ensure the team is rehearsed, prepared, and resilient against threats. Since 2004, CynergisTek has been dedicated to hiring and retaining experts who bring real-life experience and hold advanced certifications to support and educate the industry by contributing to relevant industry associations. For more information, visit www.cynergistek.com or follow us on Twitter or LinkedIn.
Cautionary Note Regarding Forward Looking Statements
This release contains certain forward-looking statements relating to the business of CynergisTek, Inc. These forward-looking statements are within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and can be identified by the use of forward-looking terminology such as “believes,” “expects,” “anticipates,” “would,” “could,” “intends,” “may,” “will,” or similar expressions. Such forward-looking statements involve known and unknown risks and uncertainties, including but not limited to uncertainties relating to product/services development; long and uncertain sales cycles; the ability to obtain or maintain proprietary intellectual property protection; future capital requirements; competition from other providers; the ability of the Company’s vendors to continue supplying the Company with supplies and services at comparable terms and prices; the Company’s ability to successfully compete and introduce enhancements and new features that achieve market acceptance and that keep pace with technological developments; the Company’s ability to maintain its brand and reputation and retain or replace its significant customers; cybersecurity risks and risks of damage and interruptions of information technology systems; the Company’s ability to retain key members of management and successfully integrate new executives; the Company’s ability to complete acquisitions, strategic investments, entry into new lines of business, divestitures, mergers or other transactions on acceptable terms, or at all; potential risks and uncertainties relating to the existing and ultimate impact of COVID-19, including the geographic spread, the severity of the virus, the duration of the COVID-19 outbreak, actions that may be taken by governmental authorities to contain the COVID-19 outbreak or to treat its impact, and the potential negative impacts of COVID-19 on the global economy and financial markets, and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Certain of these risks and uncertainties are or will be described in greater detail in the Company’s Form 10-K and Form 10-Q filings with the Securities and Exchange Commission, which are available at http://www.sec.gov. Given the risks and uncertainties, readers should not place undue reliance on any forward-looking statement and should recognize that the statements are predictions of future results which may not occur as anticipated. Many of the risks listed above have been, and may further be, exacerbated by the COVID-19 pandemic, including its impact on the healthcare industry. Actual results could differ materially from those anticipated in the forward-looking statements and from historical results, due to the risks and uncertainties described herein, as well as others not now anticipated. CynergisTek is under no obligation (and expressly disclaims any such obligation) to update or alter its forward-looking statements whether as a result of new information, future events, or otherwise.
CynergisTek Investor Relations Contact:
(512) 402-8550 x7
CynergisTek Media Contact:
Allison + Partners